Ms. Gearhart’s presentation, “IRB Review of Registries, Databases and Biobanking,” focuses on the regulatory considerations involved with the collection, storage, and distribution of human biological specimens used in clinical research.
Seattle, WA (PRWEB) March 21, 2013
Quorum Review IRB, the industry leader in central IRB services, announces CEO Cami Gearhart, JD, as a featured presenter at the upcoming Association for the Accreditation of Human Research Protection Programs (AAHRPP) International Conference held in Miami, FL, on Friday, April 5th, 2013.
Ms. Gearhart’s presentation, “IRB Review of Registries, Databases and Biobanking,” focuses on the regulatory considerations involved with the collection, storage, and distribution of human biological specimens used in clinical research. Gearhart’s presentation covers an introduction to bio-repositories, the regulatory statutes and related guidance defining IRB review, as well as considerations when submitting such research for IRB review.
Ms. Gearhart originally joined Quorum Review as a member of the IRB, and was appointed CEO in 2006. She has led the Quorum business through two AAHRPP accreditations and a successful expansion into Canada. Prior to joining Quorum Review, Ms. Gearhart practiced law in both the private sector, specializing in health care regulatory law for hospitals, clinics and other institutions, and the public sector, working for the Office of Attorney General protecting vulnerable populations. Ms. Gearhart also serves as Treasurer of the Consortium of Institutional Review Boards and Vice President for the Northwest Association for Biomedical Research’s Board of Directors.
The 2013 AAHRPP Conference offers programs that support AAHRPP’s mission of promoting high-quality clinical research and human research protection through its accreditation programs. More information about the 2013 conference is available on the AAHRPP website.
For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.
About Quorum Review
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.